Medical Journals

Repression of Prostaglandin Dehydrogenase by Epidermal Growth Factor and Snail Increases Prostaglandin E2 and Promotes Cancer Progression.

Authors:
  • Mann Jason R
  • Backlund Michael G
  • Buchanan F Gregory
  • Daikoku Taki
  • Holla Vijaykumar R
  • Rosenberg Daniel W
  • Dey Sudhansu K
  • DuBois Raymond N

From: Departments of Cell and Developmental Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2300 Pierce Avenue, Nashville, TN 37232, USA.

Cancer research

  • Publish Date: Jul 2006
  • ISSN: 0008-5472
  • Volume: 66
  • Issue: 13
  • Pages: 6649-56
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mann Jason R, Backlund Michael G, Buchanan F Gregory, et al. Repression of Prostaglandin Dehydrogenase by Epidermal Growth Factor and Snail Increases Prostaglandin E2 and Promotes Cancer Progression.. Cancer Res. Jul 2006;66:6649-56

Abstract

Prostaglandin E(2) (PGE(2)), a proinflammatory bioactive lipid, promotes cancer progression by modulating proliferation, apoptosis, and angiogenesis. PGE(2) is a downstream product of cyclooxygenase (COX) and is biochemically inactivated by prostaglandin dehydrogenase (PGDH). In the present study, we investigated the mechanisms by which PGDH is down-regulated in cancer. We show that epidermal growth factor (EGF) represses PGDH expression in colorectal cancer cells. EGF receptor (EGFR) signaling induces Snail, which binds conserved E-box elements in the PGDH promoter to repress transcription. Induction of PGE(2) catabolism through inhibition of EGFR signaling blocks cancer growth in vivo. In human colon cancers, elevated Snail expression correlates well with down-regulation of PGDH. These data indicate that PGDH may serve a tumor suppressor function in colorectal cancer and provide a possible COX-2-independent way to target PGE(2) to inhibit cancer progression.

Mesh Headings (Keywords): Animals, Colorectal Neoplasms, Dinoprostone, Disease Progression, Down-Regulation, Epidermal Growth Factor, HCT116 Cells, HT29 Cells, Humans, Hydroxyprostaglandin Dehydrogenases, Mice, Mice, Inbred C57BL, Receptor, Epidermal Growth Factor, Transcription Factors, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 16818638


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.